188 related articles for article (PubMed ID: 20176810)
1. The SUMO E3 ligase activity of Pc2 is coordinated through a SUMO interaction motif.
Yang SH; Sharrocks AD
Mol Cell Biol; 2010 May; 30(9):2193-205. PubMed ID: 20176810
[TBL] [Abstract][Full Text] [Related]
2. A role for non-covalent SUMO interaction motifs in Pc2/CBX4 E3 activity.
Merrill JC; Melhuish TA; Kagey MH; Yang SH; Sharrocks AD; Wotton D
PLoS One; 2010 Jan; 5(1):e8794. PubMed ID: 20098713
[TBL] [Abstract][Full Text] [Related]
3. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
Zhang J; Goodson ML; Hong Y; Sarge KD
J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2.
Roscic A; Möller A; Calzado MA; Renner F; Wimmer VC; Gresko E; Lüdi KS; Schmitz ML
Mol Cell; 2006 Oct; 24(1):77-89. PubMed ID: 17018294
[TBL] [Abstract][Full Text] [Related]
5. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
Reverter D; Lima CD
Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
[TBL] [Abstract][Full Text] [Related]
6. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
7. Control of nuclear HIPK2 localization and function by a SUMO interaction motif.
de la Vega L; Fröbius K; Moreno R; Calzado MA; Geng H; Schmitz ML
Biochim Biophys Acta; 2011 Feb; 1813(2):283-97. PubMed ID: 21145359
[TBL] [Abstract][Full Text] [Related]
8. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
Yang WS; Campbell M; Kung HJ; Chang PC
J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443041
[TBL] [Abstract][Full Text] [Related]
9. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
[TBL] [Abstract][Full Text] [Related]
10. The CTCF insulator protein is posttranslationally modified by SUMO.
MacPherson MJ; Beatty LG; Zhou W; Du M; Sadowski PD
Mol Cell Biol; 2009 Feb; 29(3):714-25. PubMed ID: 19029252
[TBL] [Abstract][Full Text] [Related]
11. The polycomb protein Pc2 is a SUMO E3.
Kagey MH; Melhuish TA; Wotton D
Cell; 2003 Apr; 113(1):127-37. PubMed ID: 12679040
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of yeast PIAS-type SUMO ligases in vivo and in vitro.
Takahashi Y; Toh-E A; Kikuchi Y
J Biochem; 2003 Apr; 133(4):415-22. PubMed ID: 12761287
[TBL] [Abstract][Full Text] [Related]
13. Multiple activities contribute to Pc2 E3 function.
Kagey MH; Melhuish TA; Powers SE; Wotton D
EMBO J; 2005 Jan; 24(1):108-19. PubMed ID: 15592428
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1.
Bernier-Villamor V; Sampson DA; Matunis MJ; Lima CD
Cell; 2002 Feb; 108(3):345-56. PubMed ID: 11853669
[TBL] [Abstract][Full Text] [Related]
15. The RanBP2/RanGAP1*SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase.
Werner A; Flotho A; Melchior F
Mol Cell; 2012 May; 46(3):287-98. PubMed ID: 22464730
[TBL] [Abstract][Full Text] [Related]
16. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
17. Pc2 and SUMOylation.
Wotton D; Merrill JC
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1401-4. PubMed ID: 18031231
[TBL] [Abstract][Full Text] [Related]
18. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G
Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673
[TBL] [Abstract][Full Text] [Related]
19. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
Subramanian L; Benson MD; Iñiguez-Lluhí JA
J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
[TBL] [Abstract][Full Text] [Related]
20. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
Parker JL; Ulrich HD
Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
